Literature DB >> 5776551

Coagulation factors in chronic liver disease.

G W Donaldson, S H Davies, A Darg, J Richmond.   

Abstract

Coagulation studies were carried out on 30 patients with chronic liver disease. The clotting defect was complex and involved factors V, VII, IX (Christmas factor), and prothrombin. Some patients showed a significant depression of factor IX in the presence of a normal one-stage prothrombin time. Thrombotest was found to be a good indicator of factor IX deficiency in this group of patients and may be of use as an additional liver function test. The screening of patients with liver disease for surgery or liver biopsy should assess the coagulation factors involved in both intrinsic and extrinsic thromboplastin generation.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5776551      PMCID: PMC474033          DOI: 10.1136/jcp.22.2.199

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  THE THROMBOTEST REAGENT AND CHRISTMAS DISEASE.

Authors:  P KIDD; K W DENSON; R BIGGS
Journal:  Lancet       Date:  1963-09-07       Impact factor: 79.321

2.  THE ASSESSMENT OF LIVER FUNCTION.

Authors:  R WILLIAMS
Journal:  Anaesthesia       Date:  1965-01       Impact factor: 6.955

3.  STATISTICAL CORRELATION OF LIVER FUNCTION TESTS WITH COAGULATION FACTOR DEFICIENCIES IN LAENNEC'S CIRRHOSIS.

Authors:  H G KUPFER; W GEE; A T EWALD; M E TURNER
Journal:  Thromb Diath Haemorrh       Date:  1964-01-01

4.  Clotting tests and other tests of the haemostatic mechanism in cirrhosis of the liver and their diagnostic significance.

Authors:  L HEDENBERG; K KORSAN-BENGTSEN
Journal:  Acta Med Scand       Date:  1962-08

5.  Levels of blood-coagulation factors during anticoagulant therapy with phenindione.

Authors:  K W DENSON
Journal:  Br Med J       Date:  1961-04-29

6.  Defibrination syndrome in pregnancy: value of various diagnostic tests.

Authors:  A A SHARP; B HOWIE; R BIGGS; D T METHUEN
Journal:  Lancet       Date:  1958-12-20       Impact factor: 79.321

7.  Coagulation defects in liver disease and response to transfusion during surgery.

Authors:  R B FINKBINER; J J McGOVERN; R GOLDSTEIN; J P BUNKER
Journal:  Am J Med       Date:  1959-02       Impact factor: 4.965

8.  Coagulation defects in liver disease.

Authors:  D C COWLING
Journal:  J Clin Pathol       Date:  1956-11       Impact factor: 3.411

9.  The thromboplastin generation test.

Authors:  R BIGGS; A S DOUGLAS
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

10.  PARTIAL THROMBOPLASTIN TIME TEST WITH KAOLIN. NORMAL RANGE AND MODIFICATIONS FOR THE DIAGNOSIS OF HAEMOPHILIA AND CHRISTMAS DISEASE.

Authors:  M O MATCHETT; G I INGRAM
Journal:  J Clin Pathol       Date:  1965-07       Impact factor: 3.411

View more
  9 in total

1.  Prothrombin complex concentrate: use in controlling the hemorrhagic diathesis of chronic liver disease.

Authors:  R L Bick; W R Schmalhorst; E Shanbrom
Journal:  Am J Dig Dis       Date:  1975-08

2.  Experimental hepatic necrosis: studies on coagulation abnormalities, plasma clearance, and organ distribution of 125I-labelled fibrinogen.

Authors:  M O Rake; P T Flute; G Pannell; K B Shilkin; R Williams
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

3.  Association of abnormal fibrin polymerisation with severe liver disease.

Authors:  G Green; L Poller; J M Thomson; I W Dymock
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

4.  Factor VII as a marker of hepatocellular synthetic function in liver disease.

Authors:  G Green; L Poller; J M Thomson; I W Dymock
Journal:  J Clin Pathol       Date:  1976-11       Impact factor: 3.411

5.  Liver transplantation in man--IV, Haemorrhage and thrombosis.

Authors:  P T Flute; M O Rake; R Williams; M J Seaman; R Y Calne
Journal:  Br Med J       Date:  1969-07-05

6.  Estimation of prothrombin in liver disease.

Authors:  P M Mannucci
Journal:  J Clin Pathol       Date:  1970-05       Impact factor: 3.411

Review 7.  Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?

Authors:  Dafna J Groeneveld; Lauren G Poole; James P Luyendyk
Journal:  J Thromb Haemost       Date:  2021-05-03       Impact factor: 16.036

8.  Factors influencing warfarin response in hospitalized patients.

Authors:  Mahmoud I Abdel-Aziz; Mostafa A Sayed Ali; Ayman K M Hassan; Tahani H Elfaham
Journal:  Saudi Pharm J       Date:  2015-02-27       Impact factor: 4.330

Review 9.  The Misunderstood Coagulopathy of Liver Disease: A Review for the Acute Setting.

Authors:  Michael F Harrison
Journal:  West J Emerg Med       Date:  2018-08-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.